Table 2. Quality assessment of included studies.
randomization | concealed allocation | blinding | incomplete outcome data | selective reporting | other biases | Qi | |
Cao 2012 | mentioned | unclear | unclear | unclear | unclear | unclear | 0.75 |
Chew 2010 | mentioned | yes, sealed opaque envelopes | no | unclear | unclear | yes, conflict of interest | 0.83 |
Eschertzhuber 2012 | mentioned | unclear | yes | unclear | unclear | unclear | 0.92 |
Li 2011 | yes, random number | unclear | unclear | unclear | unclear | unclear | 0.75 |
Ragazzi 2012 | yes, random number | unclear | unclear | unclear | unclear | unclear | 0.83 |
Russo 2012 | yes, random number | yes, sealed opaque envelopes | unclear | unclear | unclear | no | 0.83 |
Teoh 2010 | yes, random number | yes, sealed opaque envelopes | blinded to patients | unclear | unclear | yes, conflict of interest | 0.96 |
Theiler 2009 | yes, random number | unclear | blinded to operators | unclear | unclear | yes, conflict of interest | 0.88 |
Van Zundert 2012 | yes, random number | yes, sealed opaque envelopes | blinded to observer | unclear | unclear | unclear | 0.96 |
Yu 2011 | yes, random number | unclear | unclear | unclear | unclear | unclear | 0.83 |